Wed, Sep 17, 2014, 10:26 AM EDT - U.S. Markets close in 5 hrs 34 mins

Recent

% | $
Quotes you view appear here for quick access.

Yahoo! Inc. (YHOO) Message Board

whippersnapper65 399 posts  |  Last Activity: 4 minutes 49 seconds ago Member since: Jun 20, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • whippersnapper65 whippersnapper65 Aug 29, 2014 12:18 PM Flag

    Not meant to refer to your alias. The FFRF is truly obnoxious: It is a tiny atheist group that fires off letters to thousands of public agencies for expressions of religion that are permissible free expressions of religion, but cowards in the public institutions back down because they want to avoid the cost of a lawsuit, which the FFRF usually could not afford to file and pursue itself. Americans need to stand up and push back against the obnoxious militant left.

  • whippersnapper65 whippersnapper65 Aug 29, 2014 12:14 PM Flag

    We also need to expose the myth of the moderate Muzzle. Moderate Muzzles are simply not practicing their religion faithfully. It is a barbaric religion bent on conquest and submission of the infidel. It is not compatible with Western civilization. We are at war with them, and they must be defeated for the sake of all that is true and good and that we hold dear.

    But Dems and BHO play games with language to avoid and evade the truth. Fort Hood was not terrorism, it was "workplace violence." The Boston Marathon bombing wasn't terrorism either. Such PC nonsense has to stop before it brings down the U.S. ISIS is a greater threat than Al Qaeda. I fear an attack on U.S. soil has grown much, much more likely in the past six months. Our feckless president cannot be trusted to protect us. He's more interested in stoking a race war to muster up votes in the November election so that the Dems can retain the Senate. He's more interested in decimating the military with social experimentation. He's more interested in pandering to homosexuals. He's more interested in busing illegal immigrants around the country to create future Democrat voters in conservative areas. The man is a menace to the Constitution; he's the antipresident.

  • whippersnapper65 whippersnapper65 Aug 29, 2014 11:57 AM Flag

    Meanwhile the obnoxious Freedom From Religion Foundation threatened a high school with a lawsuit if it permits football players to pray for an injured teammate on the field.

    Muzzles can do whatever they want but Christians are targeted for hypervigilant extermination in this country.

    What the hell has happened to America? Answer: the stinking left has become too influential, and the American populace has become too degenerate to recognize the ruinous threat that the Democrat Party poses.

    Sentiment: Strong Buy

  • Reply to

    Marucci said "several" weeks at the cc

    by whippersnapper65 Aug 28, 2014 7:31 PM
    whippersnapper65 whippersnapper65 Aug 28, 2014 9:07 PM Flag

    In the context of original guidance that the trial would fully enroll by mid-year 2014 (end of June), "several" weeks on August 6 ought to be interpreted to refer to the lesser amounts in the otherwise acceptable range for "several" without a context.

    If you extend "several" to include nine or ten weeks, that postpones the closing of screening to mid-October, which pushes full enrollment to December or January 2015 (because dosage with Rindo doesn't begin until 2-3 months after screening). In that case, management would have been off in its original guidance for full enrollment by six months.

    Why is Marucci using weasel words like "several"?

    It just seems to be one delay after another, one bump after another, one obstacle after another, a dollar short and a day late with management over the past eight months. Good thing data hasn't had a miss. If that were to happen in this atmosphere of management being unreliable, it would decimate confidence in the company.

    Sentiment: Strong Buy

  • whippersnapper65 by whippersnapper65 Aug 28, 2014 7:31 PM Flag

    It's been 3.5 weeks since Marucci announced that screening for ACT IV would close over the next several weeks.

    "Several" does not extend to five weeks.

    If Celldex does not announce that screening has closed for ACT IV within another week, then I will begin to question his trustworthiness regarding projections.

    CDX 1135: misleading guidance
    Fully enroll ACT IV by mid-year 2014: wrong
    Close screening for ACT IV several weeks after cc: questionable

    What to make of Marucci's statements about cash sufficient to fund operations through 2016? I think that's questionable too.

    Until Marucci can deliver something for shareholders that makes the market affirm the value of Celldex, manipulators will continue to toy with the stock. Marucci's unreliable guidance isn't helping matters.

    Sentiment: Strong Buy

  • Reply to

    Green.....

    by flogonuzim Aug 28, 2014 9:51 AM
    whippersnapper65 whippersnapper65 Aug 28, 2014 5:04 PM Flag

    Not enough of it....

    Sentiment: Strong Buy

  • whippersnapper65 whippersnapper65 Aug 28, 2014 5:03 PM Flag

    Looks like the shorts did have fun today.

    Sentiment: Strong Buy

  • Reply to

    We Broke Through The 50 Day MA Yesterday

    by unagogirl Aug 27, 2014 9:52 AM
    whippersnapper65 whippersnapper65 Aug 28, 2014 5:00 PM Flag

    And it meant nothing. None of this blather about daily prices, gains, losses, technical analysis means anything unless and until CLDX closes well above $18 on high volume.

    Sentiment: Strong Buy

  • Reply to

    16.48 ask?

    by newguyhere Aug 26, 2014 12:18 PM
    whippersnapper65 whippersnapper65 Aug 26, 2014 12:23 PM Flag

    same with my online platform. must be NASDAQ related rather than brokerage related.

  • Reply to

    With this kind of move, you have to ask

    by nvstrbstr Aug 26, 2014 11:41 AM
    whippersnapper65 whippersnapper65 Aug 26, 2014 11:44 AM Flag

    Nowhere near enough shares have traded for a major short to have thrown in the towel. This is nothing compared to when the short squeeze actually occurs.

    Sentiment: Strong Buy

  • In order for the real ride up to begin, back to at least $30pps where CLDX belongs, then on to new highs.

    Sentiment: Strong Buy

  • whippersnapper65 whippersnapper65 Aug 25, 2014 6:10 PM Flag

    In two years $60 pps would look like a steal if a company were to buyout CLDX for that price.

    In 2012 people thought that Gilead drastically overpaid to acquire Pharmasset for $11 billion. That was solely to obtain the Hepatitis-C drug now called Sovaldi, which received FDA approval in 2013. Gilead just reported that Solvadi sales totaled $3.48 billion in the 2Q of this year. Anyone still think that paying $11 billion for such a drug was paying too much?

    If Varli works in combination with numerous already approved cancer treatments to bolster their effectiveness, then $120 pps will look cheap for the sales revenue that would be generated. Any company that does not pay at least $60 pps for CLDX now faces the prospect of having to pay over $150 within only two short years after Rindo and Glemba have positive outcomes in registrational studies and phase 2 Varli data are showing results that will transform cancer treatment into the cocktail immunotherapy revolution.

    Marucci and Davis know the value of what Celldex owns.

    Sentiment: Strong Buy

  • whippersnapper65 by whippersnapper65 Aug 25, 2014 3:39 PM Flag

    1. Screening has been completed for ACT IV, and the trial listing status changed to "active, not recruiting".
    2. The decision to enroll an additional 50 patients in group 2C, the confirmatory expansion arm of ReACT, because the first 23 patients enrolled showed evidence of anti-tumor activity.

    Then there will be announcements about Varli trials being initiated, ReACT data to be presented in November at SNO, ACT-IV completing accrual with the last patient being dosed, then additional guidance on trial completion or scheduled data reads for ACT IV, METRIC and ReACT.

    It will be a busy 2H of 2014, setting the stage even more for Celldex's success.

    Sentiment: Strong Buy

  • Reply to

    Adam F sees CLDX as next ITMN ?

    by dinepat203 Aug 25, 2014 11:17 AM
    whippersnapper65 whippersnapper65 Aug 25, 2014 11:32 AM Flag

    Oh, I did not see that. Thanks. Did Yahoo explain why?

  • whippersnapper65 whippersnapper65 Aug 25, 2014 11:31 AM Flag

    Yeah, funny how things worked out. So much about biotech stock manipulation sucks.

    Sentiment: Strong Buy

  • Reply to

    Adam F sees CLDX as next ITMN ?

    by dinepat203 Aug 25, 2014 11:17 AM
    whippersnapper65 whippersnapper65 Aug 25, 2014 11:24 AM Flag

    Yeah: from "Today's Dead Cat Bounce Stock" to "Takeover Target" in the span of one weekend.

    The Street is full of sheet.

    Why doesn't today's excellent Seeking Alpha profile of Celldex appear on Yahoo's summary page?

    Sentiment: Strong Buy

  • Reply to

    Roche, $8.3 BILLION for ITMN

    by networthdev Aug 24, 2014 1:37 PM
    whippersnapper65 whippersnapper65 Aug 24, 2014 3:55 PM Flag

    Like2invest, many others have got to be connecting the CLDX dots the way we have.

    The future is auspicious for CLDX longs. ITMN is a foreshadowing.

    Sentiment: Strong Buy

  • Reply to

    Roche, $8.3 BILLION for ITMN

    by networthdev Aug 24, 2014 1:37 PM
    whippersnapper65 whippersnapper65 Aug 24, 2014 3:52 PM Flag

    ITMN had 96% institutional ownership and 15% short position.

    Looks eerily similar to CLDX.

    ITMN shorts are going to get roasted badly on Monday. CLDX shorts will get incinerated when they least expect it.

    Sentiment: Strong Buy

  • Reply to

    Roche, $8.3 BILLION for ITMN

    by networthdev Aug 24, 2014 1:37 PM
    whippersnapper65 whippersnapper65 Aug 24, 2014 3:44 PM Flag

    In January and February of this year, ITMN was trading at about the same share price that CLDX is trading at now. With positive phase 3 data, the share price quadrupled overnight and then the discussions began in earnest regarding buyout, resulting in the $74 pps offer.

    Something similar will happen to CLDX, only the multiple and the eventual share price will be even higher.

    Celldex is working on cancer immunotherapy, not respiratory treatments. Canter immunotherapy is much more lucrative, especially if Varli can be used in combination with other treatments to increase their effectiveness.

    Shorts are playing a dangerous game, one that will cost them dearly. Soon one of the major institutional shorts will come to his senses, cover, and spark a short squeeze that returns CLDX to an appropriate valuation around $30 pps.

    Sentiment: Strong Buy

  • Reply to

    Roche, $8.3 BILLION for ITMN

    by networthdev Aug 24, 2014 1:37 PM
    whippersnapper65 whippersnapper65 Aug 24, 2014 3:36 PM Flag

    Celldex is working on immunotherapy for cancer, and Varli is going to be a golden goose. Management will not let it go easily.

    Sentiment: Strong Buy

YHOO
42.639-0.071(-0.17%)10:26 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.